pirenzepine has been researched along with Colonic Diseases, Functional in 2 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Colonic Diseases, Functional: Chronic or recurrent colonic disorders without an identifiable structural or biochemical explanation. The widely recognized IRRITABLE BOWEL SYNDROME falls into this category.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golovenko, OV | 1 |
| Nazarov, VA | 1 |
| Kirkin, BV | 1 |
| Gilvarry, J | 1 |
| Kenny, A | 1 |
| Fielding, JF | 1 |
2 trials available for pirenzepine and Colonic Diseases, Functional
| Article | Year |
|---|---|
[The efficacy of gastrotsepin in functional diseases of the large intestine].
Topics: Adolescent; Adult; Colonic Diseases, Functional; Gastrointestinal Motility; Humans; Intestine, Large | 1995 |
The non-effect of pirenzepine in dietary resistant irritable bowel syndrome.
Topics: Adolescent; Adult; Clinical Trials as Topic; Colonic Diseases, Functional; Dietary Fiber; Double-Bli | 1989 |